ASD Clinical Trial
Official title:
A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders
NCT number | NCT06339359 |
Other study ID # | 2024-02-014 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2024 |
Est. completion date | March 31, 2025 |
Verified date | March 2024 |
Source | Bundang CHA Hospital |
Contact | Kim MinYoung |
Phone | 82-31-780-6281 |
kmin[@]cha.ac.kr | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to collect basic data to develop a tool for early screening of autism spectrum disorder (ASD) in children and adolescents through eye tracking and motion analysis.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | March 31, 2025 |
Est. primary completion date | March 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 19 Years |
Eligibility | Inclusion Criteria: - Children and adolescents under the age of 19 at the time of registration - A person whose legal representative voluntarily decides to participate and agrees in writing to comply with the precautions after receiving a detailed explanation of this study and fully understanding it Exclusion Criteria: - Those with abnormalities in hearing and vision - Those who are likely to have difficulty participating in the study according to the judgment of the clinical investigator - If the visits set out in this research plan are not followed or the patient's guardian does not cooperate due to low understanding of the patient. |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | CHA Bundang Medical Center, CHA University | Seongnam-si | Gyeonggi-do |
Lead Sponsor | Collaborator |
---|---|
Bundang CHA Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | K-BSID-? | Measurement of K-BSID-? is a developmental test administered to infants from 16 days old to 42 months old, and consists of 16 subtests measuring a total of 5 development areas (cognitive, language, motor, social-emotional, and adaptive behavior). | Between March 2024 and March 2025 | |
Primary | ADI-R | Measurement of ADI-R is a test conducted to screen autism spectrum disorder from other developmental disabilities in children with a mental age of 2 years or older, and is conducted through a structured interview with the primary caregiver. | Between March 2024 and March 2025 | |
Primary | M-CHAT | Measurement of M-CHAT is a tool to screen the risk level of autism spectrum disorder in children aged 16 to 30 months and is evaluated based on the primary caregiver's report. | Between March 2024 and March 2025 | |
Primary | ADOS-2 | Measurement of ADOS-2 is a standardized assessment tool that evaluates social interaction and stereotyped and repetitive behavior in people suspected of having autism spectrum disorder. | Between March 2024 and March 2025 | |
Primary | K-WPPSI-? | Measurement of K-WPPSI-? is an intelligence test to evaluate cognitive function in children aged 2 years and 6 months to 7 years and 7 months. | Between March 2024 and March 2025 | |
Primary | K-CARS-2 | Measurement of K-CARS-2 is an one of the most widely used tools for the purpose of distinguishing autism from other developmental disabilities and the degree of autism. | Between March 2024 and March 2025 | |
Primary | CBCL | Measurement of CBCL is a useful clinical tool used in many countries around the world to evaluate social adaptation and emotional behavior problems in children and adolescents. | Between March 2024 and March 2025 | |
Primary | SCQ | Measurement of SCQ is a tool to screen symptoms related to autism spectrum disorder through parent report. | Between March 2024 and March 2025 | |
Primary | GMFM | Measurement of GMFM is a standardized observational evaluation tool with validity that measures changes in gross motor function over time in children with cerebral palsy. | Between March 2024 and March 2025 | |
Primary | HFT | Measurement of HFT is a tool to evaluate the degree of development of hand function according to age, forward arm reaching, various grasping abilities, coordination ability between both hands, and object handling ability. | Between March 2024 and March 2025 | |
Primary | BOT-2 | Measurement of BOT-2 is a testing tool used for movement training evaluation and development. | Between March 2024 and March 2025 | |
Primary | VMI-6 | Measurement of VMI-6 is a test that validly measures the visual-motor integration ability, visual perception ability, and motor coordination ability of various age groups from infants to adults. | Between March 2024 and March 2025 | |
Primary | SP | Measurement of SP is a standardized tool for assessing children's sensory processing patterns in the context of everyday life, providing unique information about how sensory processing supports or hinders participation. | Between March 2024 and March 2025 | |
Primary | Eye Tracking | While the subject watches the video material being played, gaze and behavioral data are recorded. | Between March 2024 and March 2025 | |
Primary | Motion Analysis | Measurement of Motion analysis is an evaluation process of the research subject is filmed while administering ADOS and RBS-EC. | Between March 2024 and March 2025 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT04771338 -
Examining the Effects of a Job Entry Intervention
|
N/A | |
Completed |
NCT04178421 -
Computerized Eye-tracking Attention Training for Children With Special Needs
|
N/A | |
Completed |
NCT02985749 -
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
|
Phase 3 | |
Recruiting |
NCT06012903 -
Lower Urinary Tract Symptoms and School Functioning in Children
|
||
Not yet recruiting |
NCT04418921 -
Improving Self-regulation in Children With Neurodevelopmental Disorders:
|
N/A | |
Completed |
NCT01931033 -
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
|
N/A | |
Recruiting |
NCT04899544 -
Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism
|
N/A | |
Recruiting |
NCT06155214 -
Developmental Regression-related Disease Research and Achievement Transformation Innovation Team
|
||
Active, not recruiting |
NCT01932515 -
Diagnostic Instruments for Autism in Deaf Children Study
|
N/A | |
Recruiting |
NCT06188429 -
Peripheral Blood VA/TREM2 Levels and Their Correlation Analysis With the Development and Autistic Symptoms in Children With ASD
|
||
Completed |
NCT06209463 -
Posture, Hand Functions and Sensory Processing Skills on Nutrition
|
||
Recruiting |
NCT06155201 -
Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders
|
N/A | |
Recruiting |
NCT03502239 -
Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD
|
N/A | |
Withdrawn |
NCT03829878 -
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
|
Phase 2 | |
Recruiting |
NCT02461446 -
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
|
||
Completed |
NCT03900923 -
Cannabidiol for ASD Open Trial
|
Phase 2 | |
Completed |
NCT03099239 -
hCT-MSCs for Children With Autism Spectrum Disorder (ASD)
|
Phase 1 | |
Terminated |
NCT05733390 -
A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
|
Phase 2 |